China National Pharmaceutical Group

Chinese state-owned pharmaceutical company

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Nicoletta Lanese
April 9, 2021
livescience.com
Here's a quick guide to the COVID-19 vaccines now in use around the world.
Reuters
August 18, 2020
@bsindia
A potential coronavirus vaccine being developed by a unit of China National Pharmaceutical Group could cost no more than 1,000 yuan ($144.27) for two shots
Reuters Editorial
June 17, 2020
IN
Beijing-based TravelSky Technology Ltd is advising its employees to take a candidate vaccine being developed by China National Pharmaceutical Group (Sinopharm) amid the capital's latest COVID-19 flare-up, state newspaper Global Times reported.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.